Julianna Goenaga

Julianna Goenaga

Auto-generated profile, based on publicly available information

Julianna Goenaga

Department of Neuroscience, University of Minnesota, Minneapolis, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2019 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
MNMark D. Namba
Mark D. Namba
YKYonatan M. Kupchik
Yonatan M. Kupchik
SSSade Spencer
Sade Spencer
CGConstanza Garcia-Keller
Constanza Garcia-Keller
JGJulianna G. Goenaga
Julianna G. Goenaga
CGCassandra D. D Gipson
Cassandra D. D Gipson

7 February 2019 in Addiction Biology
Verified
Journal Article
Closed access
PDF file
JGJulianna Goenaga
Julianna Goenaga
GPGregory Powell
Gregory Powell
JLJonna M. Leyrer‐Jackson
Jonna M. Leyrer‐Jackson
JPJose Piña
Jose Piña
SPSandy Phan
Sandy Phan
CGCassandra D. D Gipson
Cassandra D. D Gipson

10 January 2019 in Physiological Reports
Verified
Journal Article
Open access
PDF file
GPGregory L. Powell
Gregory L. Powell
JLJonna M. Leyrer-Jackson
Jonna M. Leyrer-Jackson
JGJulianna Goenaga
Julianna Goenaga
MNMark D. Namba
Mark D. Namba
JPJose Piña
Jose Piña
CGCassandra D. D Gipson
Cassandra D. D Gipson
N‐acetylcysteine (NAC), a promising glutamatergic therapeutic agent, has shown some clinical efficacy in reducing nicotine use in humans and has been shown to reverse drug‐induced changes in glutamatergic neurophysiology. In rats, nicotine‐seeking behavior is associated with alterations in glutamatergic plasticity within the nucleus accumbens core (NAcore). Specifically, cue‐induced nicotine‐seeking is associated with rapid, transient synaptic plasticity (t‐SP) in glutamatergic synapses on NAcore medium spiny neurons. The goal of the present study was to determine if NAC reduces nicotine‐seeking behavior and reverses reinstatement‐associated NAcore glutamatergic alterations. Rats were extinguished from nicotine self‐administration, followed by subchronic NAC administration (0 or 100 mg/kg/d) for 4 days prior to cue‐induced reinstatement. NAcore synaptic potentiation was measured via dendritic spine morphology and mRNA and protein of relevant glutamatergic genes were quantified. Nicotine‐seeking behavior was not reduced by subchronic NAC treatment. Also, NAcore transcript and protein expression of multiple glutamatergic genes, as well as spine morphological measures, were unaffected by subchronic NAC. Finally, chronic NAC treatment (15 days total) during extinction and prior to reinstatement significantly decreased extinction responding and reduced reinstatement of nicotine‐seeking compared to vehicle. Together, these results suggest that chronic NAC treatment is necessary for its therapeutic efficacy as a treatment strategy for nicotine addiction and relapse.

26 January 2018 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
POPaula Overby
Paula Overby
CDCarter W. Daniels
Carter W. Daniels
AFArmani Del Franco
Armani Del Franco
JGJulianna Goenaga
Julianna Goenaga
GPGregory Powell
Gregory Powell
FSFederico Sanabria
Federico Sanabria

31 March 2017 in Psychopharmacology
Verified
Journal Article
Closed access
PDF file
NPNatalie A. Peartree
Natalie A. Peartree
KHKayla N. Hatch
Kayla N. Hatch
JGJulianna G. Goenaga
Julianna G. Goenaga
NDNora R. Dado
Nora R. Dado
HMHanna Molla
Hanna Molla
JNJanet L. Neisewander
Janet L. Neisewander

10 April 2025 in Molecular Neurobiology
Verified
Journal Article
Open access
PDF file
JGJulianna Goenaga
Julianna Goenaga
CFCarmen Perez de Nanclares Fernandez
Carmen Perez de Nanclares Fernandez
MHMegan Hall
Megan Hall
KPKofuji Paulo
Kofuji Paulo
PMPaul G. Mermelstein
Paul G. Mermelstein
AAAlfonso Araque
Alfonso Araque
Accumulating evidence has revealed the existence of functional astrocyte-neuron communication based on the ability of astrocytes to respond to neurotransmitters and release gliotransmitters. However, little is known about how other signaling molecules, such as hormones, impact astrocyte function. Estradiol (E2) is an important hormone known to regulate neuronal activity, synaptic transmission, plasticity, and animal behavior. However, whether E2 specifically signals to astrocytes in situ and the functional consequences on astrocyte-neuron communication remain unknown. Therefore, we investigated the impact of estradiol on astrocyte activity and astrocyte-neuron communication in the mouse hippocampus. Using an RNAscope approach, we determined that estrogen receptors (ERα and ERβ) are expressed in astrocytes in both female and male mice. In both sexes, confocal imaging of hippocampal slices determined that astrocytes respond to locally applied E2 with calcium elevations. In pyramidal neurons, slow inward currents (SICs) are mediated by the activation of extrasynaptic NMDA receptors and indicate gliotransmission. Electrophysiological recordings of hippocampal neurons determined that E2 increases the frequency, but not the amplitude, of SICs. We also recorded excitatory synaptic transmission evoked by Schaffer collateral stimulation. Here, only in females, did E2 produce a reduction in excitatory synaptic transmission. The E2-induced effects on the astrocyte calcium signal and gliotransmission were prevented by the broad estrogen receptor antagonist ICI 182,780. Taken together, these results demonstrate the existence of estradiol-mediated astrocyte-neuron communication in both female and male mice. They reveal that E2 can signal to astrocytes and, through this signaling, E2 may regulate neuronal activity and synaptic transmission.